Find uplifting stories about heroes, innovations, and solutions
4392 results for "vaccine trials"
Scientists at La Jolla Institute and Scripps Research have created an HIV vaccine that triggered the strongest antibody response ever seen in primates. Human trials are now underway for a vaccine 14 years in the making.
A tetanus-diphtheria vaccine that stays effective for two years without refrigeration has passed its first human safety trial. The breakthrough could help vaccines reach millions in remote areas where keeping medicines cold is nearly impossible.
A groundbreaking personalized mRNA cancer vaccine has passed its first major clinical trial, marking a milestone in the fight against cancer. The treatment prevented melanoma from returning in patients after surgery, offering new hope for thousands facing the disease.
A new therapeutic vaccine targeting acne-causing bacteria has entered clinical trials in China, offering hope for millions who struggle with treatment-resistant breakouts. The protein-based shot marks a global shift toward immune-based solutions for the world's eighth most common skin condition.
Scientists at the University of Guelph have successfully tested the world's first vaccine against Campylobacter jejuni, a bacterial infection that causes millions of cases of severe diarrhea worldwide each year. The Phase 1 trial showed the vaccine is safe and triggers strong immune responses at even low doses.
Britain just launched a groundbreaking 24-week trial to vaccinate turkeys against bird flu, a disease that's cost the government and poultry industry up to £174 million annually. This marks a major shift in strategy that could protect food supplies and prevent devastating flock losses.
A personalized mRNA cancer vaccine combined with existing treatment stopped melanoma from returning in a major clinical trial. The breakthrough could open a powerful new way to fight cancer using the same technology that powered COVID vaccines.
A personalized vaccine combined with existing cancer treatment stopped skin cancer from coming back in over 1,000 patients during a major clinical trial. Scientists used the same mRNA technology from COVID vaccines to create custom treatments targeting each patient's unique tumor.
Scientists just gave the first human dose of a vaccine designed specifically for the Bundibugyo Ebola strain—a breakthrough that could save thousands of lives in the Democratic Republic of Congo, where over 1,000 people have already died. The vaccine went from concept to human trial in just eight weeks.
Scientists in South Africa are leading a breakthrough tuberculosis vaccine trial that could protect adolescents and adults for the first time in over a century. The M72 vaccine, combined with faster tests and shorter treatments, marks a turning point against the world's deadliest infectious disease.
For the first time in decades, a vaccine to prevent Lyme disease is showing real promise. Pfizer's new vaccine candidate demonstrated over 75% effectiveness in a major clinical trial, offering hope to millions who spend time outdoors.
%2Ffile%2Fattachments%2Forphans%2F2HIVVaccineResearch_437240.jpg)
When the US pulled funding for a groundbreaking HIV vaccine trial in Cape Town, South African scientists refused to quit. They found new backers and launched a scaled-down version that could reinvigorate global vaccine research.
A deadly tropical virus with up to 75% fatality rates finally has a vaccine candidate heading to human trials. Tokyo researchers modified the measles vaccine to protect against Nipah virus, which has killed dozens in recent outbreaks.
A groundbreaking mRNA cancer vaccine has shown promising results in preventing melanoma from returning after surgery, marking the first successful late-stage trial of its kind. The same technology behind COVID-19 vaccines could soon help thousands of cancer patients stay disease-free. #
University of Guelph researchers just cleared a major hurdle on a 20-year quest to create the world's first vaccine against campylobacter jejuni, the number one bacterial cause of severe diarrhea worldwide. The phase one human trial proved the vaccine is safe and effective at building immunity.
Scientists fast-tracked a Bundibugyo Ebola vaccine from freezer to human trials in just over two months, using lessons learned from COVID-19. With 620,000 doses already manufactured, researchers aim to begin outbreak trials in Uganda by late 2026.
Scientists in the UK and US have started testing a new bird flu vaccine on 4,000 people, taking a proactive step to prepare for potential future pandemics. The vaccine uses the same mRNA technology that proved successful with COVID-19 shots.
Scientists are racing to test vaccines that could help stop the second-largest Ebola outbreak in history. Clinical trials launching soon in the Democratic Republic of Congo offer new hope.
Scientists in Japan are launching the first human trial of a Nipah vaccine in April, targeting a virus that kills up to 75% of those infected. With no current treatment available, this breakthrough could save thousands of lives in regions where outbreaks occur.
Ethiopia just became only the second African nation to successfully complete a Phase II Marburg virus vaccine trial during an active outbreak. The breakthrough signals a major leap in the country's scientific capacity and readiness to tackle future health emergencies.
Showing 20 of 4392